Cannabinoids as Medicine

This online continuing education course provides learners with the knowledge to support patients in the safe and effective use of cannabinoid containing treatments.  Learners will be introduced to the complicated history and complex botany of the cannabis plant followed by foundational lectures on the endocannabinoid system and cannabinoid pharmacology.  The remaining lectures will focus on the use of cannabinoids for various medical conditions.  These lectures will highlight evidence that supports the use of cannabinoids for disease but will also discuss the current limitations of this evidence.  Lastly, synthetic cannabinoids and their abuse will be discussed.

Target Audience

Pharmacist
Physician

Learning Objectives

As a result of taking this course, the learner will be able to:

  1. Learn the benefits and risks to using cannabinoids to treat disease
  2. Describe the complexity of cannabinoid pharmacology
  3. Explain what evidence is currently lacking for using cannabinoids as disease treatments
  4. Discuss what clinical studies should be done to better understand the effects of various cannabinoids on disease
Course summary
Available credit: 
  • 13.50 AMA PRA Category 1 Credit
  • 13.50 University of Wisconsin–Madison Continuing Education Hours
    • 13.50 Approved for AMA PRA Category 1 Credit™
Registration opens: 
07/15/2020
Course expires: 
07/14/2023
Cost:
$0.00
Rating: 
0

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the  speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE).  In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.

*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by, or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.

For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are provided at the course site.

INSTRUCTORS

John Dopp, PharmD, MS, Associate Professor, School of Pharmacy, University of Wisconsin – Madison

Barry Gidal, PharmD, RPh, FAES,  Professor, School of Pharmacy, University of Wisconsin – Madison

Sara Hassan, BPharm, MS, PhD, School of Pharmacy, University of Wisconsin – Madison

Paul Hutson, PharmD, Professor, School of Pharmacy, University of Wisconsin – Madison

Angela Janis, MD, DFAPA, Psychiatrist, Mendota Mental Health Institute

Hunter Land, MS, Associate Director, Cannabinoid Research at Canopy Growth Corporaton

David Potter, JP, PhD, FRSB, FLS, Director of Botanical Research, GW Pharmaceuticals

Lucas Richert, PhD, Associate Professor, George Urdang Chair in the History of Pharmacy, School of Pharmacy, University of Wisconsin – Madison

Natalie Schmitz, MPA, PharmD, PhD, Assistant Professor, School of Pharmacy, University of Wisconsin – Madison

Cody Wenthur, PharmD, PhD, Assistant Professor, School of Pharmacy, University of Wisconsin – Madison

Discloser List CME Internal Report

Accreditation Statement

ICEP Logo

In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

Accreditation Council for Pharmacy Education (ACPE)

The University of Wisconsin-Madison ICEP designates this enduring knowledge-based activity for 13.5 hours (1.35 CEUs) of CPE credit. Credit can be earned by successfully completing the assessment (70% or better score) and evaluation. There will be no partial credit awarded for partial completion.

Release Date: 07/15/2020 Expiration Date: 07/15/2023

American Medical Association (AMA)

The University of Wisconsin–Madison ICEP designates this enduring activity for a maximum of 13.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Education Units (CEUs)

The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 1.35 CEUs or 13.5 hours.

Available Credit

  • 13.50 AMA PRA Category 1 Credit
  • 13.50 University of Wisconsin–Madison Continuing Education Hours
    • 13.50 Approved for AMA PRA Category 1 Credit™

Price

Cost:
$0.00
Please login or register to take this course.